logo
Restaurant Brands Earnings Drop as Expenses Climb

Restaurant Brands Earnings Drop as Expenses Climb

Restaurant Brands reported a drop in second-quarter income despite higher sales as expenses climbed.
Restaurant Brands, which houses Burger King and Tim Horton's brands, said second-quarter net income was $189 million, or 57 cents a share, compared with $280 million, or 88 cents a share, a year earlier.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hancock Whitney Second Quarter 2025 Earnings: EPS Misses Expectations
Hancock Whitney Second Quarter 2025 Earnings: EPS Misses Expectations

Yahoo

time24 minutes ago

  • Yahoo

Hancock Whitney Second Quarter 2025 Earnings: EPS Misses Expectations

Explore Hancock Whitney's Fair Values from the Community and select yours Hancock Whitney (NASDAQ:HWC) Second Quarter 2025 Results Key Financial Results Revenue: US$360.6m (up 3.2% from 2Q 2024). Net income: US$113.0m (flat on 2Q 2024). Profit margin: 31% (down from 33% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$1.32. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Hancock Whitney EPS Misses Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.8%. Looking ahead, revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are up 1.1% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Hancock Whitney's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Trupanion Second Quarter 2025 Earnings: Beats Expectations
Trupanion Second Quarter 2025 Earnings: Beats Expectations

Yahoo

time24 minutes ago

  • Yahoo

Trupanion Second Quarter 2025 Earnings: Beats Expectations

Explore Trupanion's Fair Values from the Community and select yours Trupanion (NASDAQ:TRUP) Second Quarter 2025 Results Key Financial Results Revenue: US$353.6m (up 12% from 2Q 2024). Net income: US$9.41m (up from US$5.86m loss in 2Q 2024). Profit margin: 2.7% (up from net loss in 2Q 2024). EPS: US$0.22 (up from US$0.14 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Trupanion Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates. Looking ahead, revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's shares are up 5.6% from a week ago. Risk Analysis It is worth noting though that we have found 2 warning signs for Trupanion that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations

Yahoo

time24 minutes ago

  • Yahoo

Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations

Sutro Biopharma (NASDAQ:STRO) Second Quarter 2025 Results Key Financial Results Revenue: US$63.7m (up 148% from 2Q 2024). Net loss: US$11.5m (loss narrowed by 76% from 2Q 2024). US$0.14 loss per share (improved from US$0.59 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Sutro Biopharma Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates significantly. Earnings per share (EPS) also surpassed analyst estimates by 63%. Looking ahead, revenue is expected to decline by 18% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 19%. Performance of the American Biotechs industry. The company's share price is broadly unchanged from a week ago. Risk Analysis It's necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with Sutro Biopharma (at least 1 which is significant), and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store